Recent advances in bladder cancer treatments may offer hope of curative care to more patients, including those with high-risk ...

However, chemotherapy can shrink tumors, sometimes making surgery a viable option. Currently, two main chemotherapy regimens are used for BRPC, but there is no clear evidence favoring one over the ...

The 22nd Annual Winter Lung Cancer Conference, January 31-February 2, 2025, will cover advances in NSCLC and SCLC treatment.

Perioperative durvalumab has “the potential to transform the standard of care” for patients with muscle-invasive bladder ...

Patients with dMMR colon cancer in a trial for two neoadjuvant cycles of nivolumab/ipilimumab or nivolumab/relatlimab, had ...

Chemotherapy for three months demonstrates lower side effects, suggesting its use as standard care compared with six months.

Doctors are hoping an expanded chemo treatment plan would help wipe away any stray cancer cells in pancreatic cancer patients ...

Platinum-based chemotherapy has long been the standard treatment for metastatic bladder cancer and for muscle-invasive bladder cancer where neoadjuvant chemotherapy is delivered prior to surgery.

Dongan Hills resident Melissa Hickey turned her chemotherapy sessions into carnivals, movie sets and tea parties.

Neoadjuvant atezolizumab has a low rate of significant toxicity or disease progression in patients with advanced cSCC. The high pathological response rate can confer a clinical benefit from reduced ...

IMNN-001 immunotherapy plus standard-of-care chemotherapy resulted in 35% improvement in overall survival and 25% improvement in progression-free ...

5 Thus, a placebo group with neoadjuvant chemotherapy will be more appropriate when considering the design of subsequent phase 3 trials. The contribution of concurrent and adjuvant checkpoint ...